Skip to main content
Clinical Trials/NCT06641687
NCT06641687
Recruiting
Not Applicable

Oral Sucrose for Pain Management During Flexible Nasolaryngoscopy

The Hospital for Sick Children1 site in 1 country60 target enrollmentSeptember 23, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infant Conditions
Sponsor
The Hospital for Sick Children
Enrollment
60
Locations
1
Primary Endpoint
Pain Scores
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

The investigators want to know if sugar water containing 24% sucrose is helpful in reducing pain in babies during scopes.

Detailed Description

This study aims to evaluate the impact of oral sucrose on pain or distress in outpatient infants undergoing flexible nasolaryngoscopy during a scheduled appointment at the SickKids Pediatric Otolaryngology Clinic.

Registry
clinicaltrials.gov
Start Date
September 23, 2024
End Date
September 1, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nikolaus Wolter

Staff Otolaryngologist, Department of Otolaryngology - Head & Neck Surgery

The Hospital for Sick Children

Eligibility Criteria

Inclusion Criteria

  • Patient \<12 months of age;
  • Scheduled for an appointment with Dr. Nikolaus Wolter or Dr. Jennifer Siu, who are Staff Pediatric Otolaryngologists at the Hospital for Sick Children, or Meghan Tepsich, a complex airway Nurse Practitioner at SickKids;
  • Requiring flexible nasolaryngoscopy for diagnostic purposes;
  • Accompanied by caregivers who provided consent.

Exclusion Criteria

  • Patient \>12 months of age
  • Infants \<37 weeks corrected gestational age
  • Infants with decreased level of consciousness or delayed neuromuscular development with limited pain response
  • Infants who have received acute/urgent /emergent airway assessment such as respiratory distress or a foreign body, etc.
  • Infants who have received topical anesthesia (topical decongestant/anesthetic spray)
  • Infants with the following conditions, where oral sucrose is contraindicated or ineffective:
  • Carbohydrate intolerance
  • Decreased level of consciousness or heavy sedation
  • Absent gag reflex
  • Non-functional gastrointestinal tract

Outcomes

Primary Outcomes

Pain Scores

Time Frame: up to 7 months

Clinical pain scores change after flexible nasolaryngoscopy (FNL) in 60 infants under 12 months of age following the use of sucrose solutions. The EVENDOL scale is a validated 15-point scale (range of 0-15) developed for children with presenting, prolonged, or procedural pain. Infant pain observations are ranked from 0-3 based on 5 different observations: (1) vocal or verbal expression, (2) facial expression, (3) movements, (4) postures, and (5) interactions with the environment. Higher scores mean a worse outcome (more pain).

Secondary Outcomes

  • Crying time(up to 7 months)
  • Maximum Heart rate(up to 7 months)
  • Time to baseline(up to 7 months)
  • Plantar skin conductance(up to 7 months)
  • Duration of clinic visit(up to 7 months)
  • Caregiver impression(up to 7 months)

Study Sites (1)

Loading locations...

Similar Trials